Loading... Please wait...
Contact Us
Would you like more
information on this report
Please contact us today at +44(0)20.7665.9240
or +1 212.220.0880
or write to us.

Medical Affairs Reputations: Asthma/COPD (US)

Product Code:
596200402
Publication Date:
November 2015
Format:
PowerPoint
Price:
£5,375

How well does your Asthma/COPD medical affairs team compare with your rivals in the US?

Which brand's medical affairs team is perceived to be the best and which is the worst? Who scored almost 5 times better on the quality of overall interactions than the worst performers?

Find out how well your medical affairs team ranks and where physicians are still looking for improvements – specifically from your team and more generally. Get the report now.

Don't forget, if you also buy the  EU5 version you'll get a free comparison report, saving you time understanding and analysing the differences uncovered between these crucial markets.

Request Sample Pages

Brands covered

Packed with physician insight into seven of the leading asthma/COPD brands:

  • AstraZeneca
    Symbicort (Budesonide/Formoterol)
    Tudorza (Aclidinium)
  • Boehringer Ingelheim
    Spiriva (Tiotropium)
  • Forest Laboratories
    Daliresp (Roflumilast)
  • Genentech / Novartis
    Xolair (Omalizumab)
  • GlaxoSmithKline
    Advair (Fluticasone/Salmeterol)
    Anoro Ellipta (Umeclidinium/Vilanterol)
  • Novartis
    Arcapta (Indacaterol)

Request Sample Pages

Top Takeaways

  • Reputations vary considerably: There is a wide spread in how the individual teams are perceived in the important categories with some teams consistently highly rated
  • Physicians think there’s a solid performance: Areas of high importance score best overall
  • Important areas scored higher: Medical affairs teams score more room for improvement in areas of lower importance
  • Information needs score highest: Highest satisfaction is achieved around fulfilling information requirements
  • US outperforming EU5: Physicians rate US medical affairs teams higher – with more scores for solid performance
  • 1 brand lags behind: Who scored lowest on all important attributes?

Request Sample Pages

Key issues explored

  • The reputations of the medical affairs teams specialising in asthma/COPD evaluated using proprietary analysis and visualisation tools to show how the teams are perceived
  • How medical affairs teams are being used by physicians and where they are seeking support
  • How often physicians want contact with medical affairs teams
  • What services from medical affairs teams are considered the most and least important
  • Analysis of performance and where improvement is still needed across key categories, both overall and on a drug-by-drug basis

Request Sample Pages

Methodology

  • A mix total of 100 pulmonologists (67) and general practitioners (33) across the US participated in this study
  • Data was collected via a 15-minute internet-based questionnaire

Participants screened to ensure they:

  • See at least 50 patients for asthma or COPD in a typical month
  • Have been in active practice between 3-35 years
  • Devote at least 50% of their time to direct patient care
  • Have interacted with a medical affairs professional in the past 6 months for at least 1 of the listed products

Request Sample Pages

About FirstWord

FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence.

  • FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your company’s success.
  • FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. Covering biosimilars, market access, medical affairs, sales & marketing, technology and therapy areas, FirstWord Reports provide expert views and intelligence on the challenges facing pharma today.

Learn more at www.firstwordgroup.com.

Request Sample Pages




customer.service@firstwordpharma.com

All Contents Copyright © 2019 Doctor's Guide Publishing Limited All Rights Reserved